Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard H Feldman

Showing results (11-20 of 160) with videos related to

Pageof 16
Sort By:
Journal of Neuropathology and Experimental Neurology|August 18, 2005
Ubiquitin immunohistochemistry suggests classic motor neuron disease, motor neuron disease with dementia, and frontotemporal dementia of the motor neuron disease type represent a clinicopathologic spectrumIan R A Mackenzie, Howard H Feldman
Alzheimer'S Research & Therapy|September 1, 2019
The "rights" of precision drug development for Alzheimer's diseaseJeffrey Cummings, Howard H Feldman, Philip Scheltens
Expert Opinion on Pharmacotherapy|September 23, 2008
Pharmacological treatment in moderate-to-severe Alzheimer's diseaseGing-Yuek Robin Hsiung, Howard H Feldman
JAMA Neurology|April 21, 2025
IWG and AA Criteria-Where the Differences Matter-ReplyBruno Dubois, Nicolas Villain, Howard H Feldman
Neurology|November 15, 2006
Dropouts and refusals in observational studies: lessons for prevention trialsClaudia Jacova, Ging-Yuek R Hsiung, Howard H Feldman
Progress in Neurobiology|September 3, 2020
Sleep and its regulation: An emerging pathogenic and treatment frontier in Alzheimer's diseaseBrianne A Kent, Howard H Feldman, Haakon B Nygaard
Alzheimer'S Research & Therapy|February 26, 2014
Definitions of dementia and predementia states in Alzheimer's disease and vascular cognitive impairment: consensus from the Canadian conference on diagnosis of dementiaHoward Chertkow, Howard H Feldman, Claudia Jacova, et al.
Alzheimer Disease and Associated Disorders|November 30, 2006
Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatmentHoward H Feldman, Frederick A Schmitt, Jason T Olin, et al.
Journal of the Neurological Sciences|March 8, 2007
Clinical phenotypes of Cerebral Amyloid AngiopathyLuís F Maia, Ian R A Mackenzie, Howard H Feldman
The Lancet. Neurology|May 23, 2025
The International Working Group recommendations on cognitively unimpaired individualsNicolas Villain, Giovanni B Frisoni, Howard H Feldman, et al.
Pageof 16

Showing results (11-20 of 160) with videos related to

Sort By:
Pageof 16
Journal of Neuropathology and Experimental Neurology|August 18, 2005
Ubiquitin immunohistochemistry suggests classic motor neuron disease, motor neuron disease with dementia, and frontotemporal dementia of the motor neuron disease type represent a clinicopathologic spectrumIan R A Mackenzie, Howard H Feldman
Alzheimer'S Research & Therapy|September 1, 2019
The "rights" of precision drug development for Alzheimer's diseaseJeffrey Cummings, Howard H Feldman, Philip Scheltens
Expert Opinion on Pharmacotherapy|September 23, 2008
Pharmacological treatment in moderate-to-severe Alzheimer's diseaseGing-Yuek Robin Hsiung, Howard H Feldman
JAMA Neurology|April 21, 2025
IWG and AA Criteria-Where the Differences Matter-ReplyBruno Dubois, Nicolas Villain, Howard H Feldman
Neurology|November 15, 2006
Dropouts and refusals in observational studies: lessons for prevention trialsClaudia Jacova, Ging-Yuek R Hsiung, Howard H Feldman
Progress in Neurobiology|September 3, 2020
Sleep and its regulation: An emerging pathogenic and treatment frontier in Alzheimer's diseaseBrianne A Kent, Howard H Feldman, Haakon B Nygaard
Alzheimer'S Research & Therapy|February 26, 2014
Definitions of dementia and predementia states in Alzheimer's disease and vascular cognitive impairment: consensus from the Canadian conference on diagnosis of dementiaHoward Chertkow, Howard H Feldman, Claudia Jacova, et al.
Alzheimer Disease and Associated Disorders|November 30, 2006
Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatmentHoward H Feldman, Frederick A Schmitt, Jason T Olin, et al.
Journal of the Neurological Sciences|March 8, 2007
Clinical phenotypes of Cerebral Amyloid AngiopathyLuís F Maia, Ian R A Mackenzie, Howard H Feldman
The Lancet. Neurology|May 23, 2025
The International Working Group recommendations on cognitively unimpaired individualsNicolas Villain, Giovanni B Frisoni, Howard H Feldman, et al.
Pageof 16